CV NEWS FEED // The Wall Street Journal and other media have announced that the Supreme Court decided on Monday to hear the Biden Administration’s challenge to Tennessee’s law prohibiting “gender transition care.”
According to The Wall Street Journal article, the Department of Justice contended that the Tennessee law infringes on the Constitution’s equal protection clause. It argued that the law discriminates by prohibiting medical treatments exclusively if they’re for gender dysphoria while allowing the same treatments for other conditions, such as precocious puberty.
A federal appeals court in Cincinnati dismissed that argument, with Chief Judge Jeffrey Sutton of the Sixth U.S. Circuit Court of Appeals writing, “The unsettled, developing, in truth still experimental, nature of treatments in this area surely permits more than one policy approach, and the Constitution does not favor one over the other.”
As CatholicVote previously reported, Tennessee is one of many states that have banned or restricted “gender-affirming” medication. The state joins South Carolina and over 23 other states amid the growing unpopularity of allowing “gender-affirming” medication for minors.
The case will be argued in the Supreme Court’s upcoming term, which starts in October, The Wall Street Journal reported. This litigation arises at a time when transgender issues have taken center stage in state legislatures nationwide. It positions the justices at the center of a national debate on gender ideology.
